Immune responsiveness during disease progression from acute rheumatic fever to chronic rheumatic heart disease

Microbes and Infection

Volumn 14, Issue 12, 2012, Pages 1111-1117

  Toor, Devinder ^a   Vohra, Harpreet ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

FACS; Rheumatic fever; Rheumatic heart disease; Th1 Th2 cytokines

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANTIBODY PRODUCTION; ARTICLE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART VALVE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOASSAY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SCHOOL CHILD; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL; TISSUE INJURY;

ADOLESCENT; ADULT; CD4-CD8 RATIO; CHILD; CHRONIC DISEASE; CYTOKINES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; RHEUMATIC FEVER; STREPTOCOCCUS PYOGENES; TH1 CELLS; TH2 CELLS; UNITED STATES; YOUNG ADULT;

STREPTOCOCCUS PYOGENES;

EID: 84866323300     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.07.003     Document Type: Article

References (31)

1. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal disease. Lancet Infect. Dis. 2005, 5:685-694.
2. Cunningham M.W. Pathogenesis of group A streptococcus infections. Clin. Microbiol. Rev. 2000, 13:470-511.
3. Veasy L.G., Hill H.R. Immunologic and clinical correlation in rheumatic fever and rheumatic heart disease. Pediatr. Infect. Dis. J. 1997, 16:400-407.
4. Ellis N.M., Kurahara D.K., Vohra H., Mascaro-Blanco A., Erdem G., Adderson E.E., Veasy L.G., Stoner J.A., Tam E., Hill H.R., Yamaga K., Cunningham M.W. Priming the immune system for heart disease: a perspective on group A streptococci. J. Infect. Dis. 2010, 202:1059-1067.
5. Martins T.B., Hoffman J.L., Augustine N.H., Phansalkar A.R., Fischetti V.A., Zabriskie J.B., Cleary P.P., Musser J.M., Veasy L.G., Hill H.R. Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever. Int. Immunol. 2008, 20:445-452.
6. Kemeny E., Grieve T., Marcus R., Sareli P., Zabriskie J.B. Identification of mononuclear cells and T cells in rheumatic valvulitis. Clin. Immunol. Immunopathol 1989, 52:225-237.
7. Read S.E., Reid F.M., Fischetti V.A., Poon-King T., Kamkissoon R., McDowell M., Zabriskie J.B. Serial studies on the cellular immune response to streptococcal antigens in acute and convalescent rheumatic fever patients in Trinidad. J. Clin. Immunol. 1986, 6:433-441.
8. Lue H.C., Tseng W.P., Lin G.J., Hsieh K.H., Hsieh R.P., Chiou J.F. Clinical and epidemiological features of rheumatic fever and rheumatic heart disease in Taiwan and the Far East. Indian Heart J. 1983, 35:139-146.
9. Ganguly N.K., Anand I.S., Khanna A.K., Kohli K.S., Wahi P.L. T cells and T cell subsets in rheumatic heart disease. Indian J. Med. Res. 1982, 76:854-858.
10. Bhatia R., Narula J., Reddy K.S., Koicha M., Malaviya A.N., Pothinerai R.B., Tandon R. Lymphocyte subsets in acute rheumatic fever and acute rheumatic heart disease. Clin. Cardiol. 1989, 2:34-38.
11. Guilherme L., Cunha-Neto E., Tanaka A.C., Dulphy N., Toubert A., Kalil J. Heart-directed autoimmunity: the case of rheumatic fever. J. Autoimmun. 2001, 16:363-367.
12. Morris K., Mohan C., Wahi P.L., Anand I.S., Ganguly N.K. Increase in activated T cells and reduction in supressor/cytotoxic T cells in acute rheumatic fever and acute rheumatic heart disease: a longitudinal study. J. Infect. Dis. 1993, 167:979-983.
13. Narin N., Kutukculer N., Ozyurek R., Bakiler A.R., Parlar A., Arcasat M. Lymphocyte subsets and plasma IL-1α, IL-2 and TNF-α concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin. Immunol. Immunopathol 1995, 77:172-176.
14. Ellis N.M., Li Y., Hildebrand W., Fischetti V.A., Cunningham M.W. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J. Immunol. 2005, 175:5448-5456.
15. Roberts S., Kosanke S., Dunn S.T., Jankelow D., Duran C.N.G., Cunningham M.W. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J. Infect. Dis. 2001, 183:507-511.
16. Morris K., Mohan C., Wahi P.L., Anand I.S., Ganguly N.K. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and rheumatic heart disease; a prospective study. Clin. Exp. Immunol. 1993, 91:429-436.
17. Faé K.C., da Silva D.D., Oshiro S.E., Tanaka A.C., Pomerantzeff P.M., Douay C., Charron D., Toubert A., Cunningham M.W., Kalil J., Guilherme L. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J. Immunol. 2006, 176:5662-5670.
18. Zedan M.M., El-Shennawy F.A., Abou-Bakr H.M., Al-Basousy A.M. IL-2 in relation to T-cell subpopulations in rheumatic heart disease. Arch. Dis. Child. 1992, 67:1373-1375.
19. Alarcon-Riquelme M.E., Alarcon-Segovia D., Loredo-Abdala A., Alcocer-Varela J. T lymphocyte subsets, suppressor and contrasuppressor cell functions, and production of IL-2 in the peripheral blood of rheumatic fever patients and their apparently healthy siblings. Clin. Immunol. Immunopathol 1990, 55:120-128.
20. Guilherme L., Fae K.C., Oshiro S.E., Tanaka A.C., Pomerantzeff P.M., Kalil J. How S. pyogenes - primed peripheral T cells trigger heart valve lesions. Ann. N.Y. Acad. Sci. 2005, 1051:132-140.
21. Guilherme L., Fae K.C., Oshiro S.E., Kalil J. Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev. Mol. Med. 2005, 7:1-15.
22. Nistri S., Mazzetti L., Failli P., Bani D. High-yield method for isolation and culture of endothelial cells from rat coronary blood vessels suitable for analysis of intracellular calcium and nitric oxide biosynthetic pathways. Biol. Proced. Online 2002, 4:32-37.
23. Zabriskie J.B. Rheumatic fever: a model for the pathological consequences of microbial-host mimicry. Clin. Exp. Rheumatol. 1986, 4:65-73.
24. Coffman R.L., von der Weid T. Multiple pathways for the initiation of T Helper 2 (Th2) responses. J. Exp. Med. 1997, 185:373-375.
25. Rincon M., Anguita J., Nakamura T., Fibrig E., Flavell R.A. IL-6 directs the differentiation of IL-4 producing CD4+ T cells. J. Exp. Med. 1997, 185:461-469.
26. Maeda K., Mehta H., Drevets D.A., Coggeshall K.M. IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production. Blood 2010, 115:4699-4706.
27. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today 1990, 11:443-449.
28. Cope A.P. Regulation of autoimmunity by proinflammatory cytokines. Curr. Opin. Immunol. 1998, 10:669-676.
29. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthiritis. Annu. Rev. Immunol. 1996, 14:397-440.
30. Sedgwick J.D., Rininton D.S., Cyster J.G., Komer H. Tumor necrosis factor: a master regulator of leukocyte movement. Immunol. Today 2000, 21:110-113.
31. Mantovani A., Bussolino F., Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol. Today 1997, 18:231-240.